Shenzhen Neptunus Bioengineering plans to raise CNY1bn ($150.69m) through the private placement of debt financing instruments.

The Chinese biochemical pharmaceuticals company plans to use the funds towards gold operations and repayment of debt.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Indian pharmaceutical company Denis Chem Lab plans to issue 21 million shares of its common stock priced at Rs84 ($1.31) a share to raise Rs179.32m ($2.8m).

Chinese healthcare solutions provider Humanwell Healthcare (Group) plans to dispose its bio-pharma unit for CNY350m ($53.01m).

Pharmaceutical Technology Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Pharmaceutical Technology Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving pharmaceutical advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now